Arcutis Biotherapeutics ARQT SEC Filings

NASDAQ ARQT
$23.75 +0.09 (+0.36%)
As of: Sep 4, 2026 · 12:51 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Arcutis Biotherapeutics, Inc. (ARQT) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index